Technology Transfer Service
Bestbiochem seeks new drug projects from biotech companies and universities around the world, then introduces projects to pharmaceuticals and investors. We play as a communication node between researchers and pharmaceuticals, improve the speed of technology circulation.
As a third part technology transfer organization, we consider for both sides and keep honest, responsible during service.
Our services include: technology transfer, technology investment, merger and acquisition.
We focus on these areas: new drugs, new targets, generic drugs, innovative therapies, etc.
If you have projects need license-in or license-out, please contact us: elisa@bestbiochem.com
Project | Indication | Phase | Introduction |
BCW100001 | Rheumatoid arthritis | Clinical Phase I | |
BCW100002 | Ischemic cerebrovascular disease | Clinical Phase II | |
BCW100003 | Renal insufficiency | Clinical Phase II | |
BCW100004 | Chemotherapyinduced thrombocytopenia,CIT | III | |
BCW100005 | Ischemia reperfusion injury caused by acute myocardial infarction | IIa | |
BCW100006 | Xerophthalmia | Preclinical | |